FR2740223B1 - Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques - Google Patents

Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques

Info

Publication number
FR2740223B1
FR2740223B1 FR9512290A FR9512290A FR2740223B1 FR 2740223 B1 FR2740223 B1 FR 2740223B1 FR 9512290 A FR9512290 A FR 9512290A FR 9512290 A FR9512290 A FR 9512290A FR 2740223 B1 FR2740223 B1 FR 2740223B1
Authority
FR
France
Prior art keywords
blood serum
pathological complications
determining auto
antibodies
particularly diabetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9512290A
Other languages
English (en)
Other versions
FR2740223A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to FR9512290A priority Critical patent/FR2740223B1/fr
Publication of FR2740223A1 publication Critical patent/FR2740223A1/fr
Application granted granted Critical
Publication of FR2740223B1 publication Critical patent/FR2740223B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR9512290A 1995-10-19 1995-10-19 Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques Expired - Fee Related FR2740223B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9512290A FR2740223B1 (fr) 1995-10-19 1995-10-19 Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512290A FR2740223B1 (fr) 1995-10-19 1995-10-19 Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques

Publications (2)

Publication Number Publication Date
FR2740223A1 FR2740223A1 (fr) 1997-04-25
FR2740223B1 true FR2740223B1 (fr) 1997-11-14

Family

ID=9483698

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9512290A Expired - Fee Related FR2740223B1 (fr) 1995-10-19 1995-10-19 Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques

Country Status (1)

Country Link
FR (1) FR2740223B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061790A (en) * 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
CA2074790A1 (fr) * 1992-07-28 1994-01-29 H. Michael Dosch Methodes permettant de deceler l'iddm preclinique

Also Published As

Publication number Publication date
FR2740223A1 (fr) 1997-04-25

Similar Documents

Publication Publication Date Title
AU9553998A (en) Method for determining the glucose content of a blood sample
PL334897A1 (en) Visual test strip for determining glucose level in blood
EP0653068A4 (fr) Biocapteur pour determiner l'hematocrite.
AU1189599A (en) Optical method and device for determining blood glucose levels
AU2925597A (en) Optical method and device for determining blood glucose levels
AU1802899A (en) Blood analyte monitoring through subcutaneous measurement
AU2001250960A1 (en) Method for determining blood constituents
AU5876590A (en) Analysis method for determining substances from biological fluids
IL206603A0 (en) Cell surface molecule mediating cell adhesion and signal transmission
CA2336153A1 (fr) Methode de diagnostic precoce de carcinomes
AU132570S (en) Device for measuring the concentration of an analyte in a sample of blood
EP0409033A3 (en) Optical fiber sensor arrangement for determining an analyte, in particular glucose
AU132571S (en) Device for measuring the concentration of an analyte in a sample of blood
AU9424898A (en) Assay device for determining analytes in a liquid dairy product
AU4586096A (en) Sample processing method for whole blood
AU1741800A (en) Apparatus for taking blood samples
WO2000068424A3 (fr) Moyens de detection et de traitement des pathologies associees au fgfr3
IL123834A0 (en) Diagnostic method and kit for determining rh blood group genotype
AU4341700A (en) Blood control and system for erythrocyte sedimentation measurement
DE29623431U1 (de) Vorrichtung zur Blutglucosebestimmung
FR2790092B1 (fr) Procede de determination d'un analyte present dans une solution
FR2740223B1 (fr) Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques
WO1999047692A3 (fr) Procedes de detection de troubles neurologiques
CA2288080A1 (fr) Procede pour detecter de maniere fonctionnelle des dysfonctionnements dans le systeme de la proteine c
GB9626333D0 (en) Liquid control solutions for blood analysis

Legal Events

Date Code Title Description
ST Notification of lapse